Evaluation of vitamin D levels in patients with breast cancer-related lymphedema: An observational cross-sectional study
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessAttribution NonCommercial 4.0 Internationalhttps://creativecommons.org/licenses/by-nc/4.0/Tarih
2019Yazar
Sezgin Özcan, DidemDalyan, Meltem
Ergül, Serhat
Ünsal Delialioğlu, Sibel
Köseoğlu, Belma Füsun
Üst veri
Tüm öğe kaydını gösterKünye
Sezgin Özcan, D., Dalyan, M., Ergül, S., Ünsal Delialioğlu, S. ve Köseoğlu, B. F. (2019). Evaluation of vitamin D levels in patients with breast cancer-related lymphedema: An observational cross-sectional study. Turkish Journal of Osteoporosis, 25(3), 105-110. https://doi.org/10.4274/tod.galenos.2019.35119Özet
Objective: The aim of our study was to compare plasma vitamin D levels between patients with breast cancer-related lymphedema (BCRL) and healthy population, and also to investigate the effects of socio-demographic and clinical factors and lymphedema severity on vitamin D levels. Materials and Methods: Eighty patients with BCRL [mean age 55.5 +/- 8.9 (36-81)] and age- and sex-matched 80 healthy controls [mean age 53.7 +/- 7.4 (32-70)] who were not on calcium or vitamin D supplementation were included in the study. Socio-demographic and clinical characteristics of the subjects were questioned. Plasma 25-Hydroxyvitamin D3, calcium, phosphorus, alkaline phosphatase (ALP), and parathormone (PTH) levels were evaluated. Lymphedema was classified as stage 0, I, II, or III. Results: The mean duration of lymphedema was 23.5 +/- 13.8 months. Comparisons revealed lower vitamin D levels and higher PTH and ALP levels in patients with BCRL than healthy controls. As a result of multivariate regression analysis, a significant relationship was revealed between vitamin D levels and age, breast cancer stage, and disease duration in patients with BCRL. Vitamin D levels were significantly lower and PTH levels were significantly higher in stage 3 lymphedema patients compared to stage 1. Conclusion: Vitamin D levels were detected lower in patients with lymphedema than healthy controls. Although vitamin D levels were found to be lower in patients with severe lymphedema, the multivariate regression analysis revealed that the severity of lymphedema does not have a significant effect on vitamin D levels.